Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Actimid shows antitumor activity in multiple myeloma

July 15, 2002

Enzon to reacquire Oncaspar rights from Aventis

July 15, 2002

Vertex presents new caspase inhibitors for use in cancer, etc.

July 15, 2002

Novel FTase inhibitors in early development at Janssen

July 15, 2002

Dyax acquires exclusive rights to a newly discovered prostate cancer target

July 15, 2002

Phase III patient enrollment complete for histrelin implant

July 15, 2002

Plans discussed for Exherin phase I clinical trials

July 12, 2002

MediciNova acquires worldwide rights to novel cancer treatment

July 12, 2002

Selective CCK2 antagonist undergoes clinical evaluation at JB for pancreatic cancer

July 12, 2002

Combinations containing TT-232 and cytostatics examined in murine models

July 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...